20/20 Biolabs, Inc. (AIDX)

NASDAQ

$0.28

$+0.02

(+6.42%)

Previous Close: ⁦$0.27⁩

Market Closed

20/20 Biolabs, Inc. (AIDX) Live Price Chart

Last updated: ⁦2026-10-22 06:26:40⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

20/20 Biolabs, Inc. (AIDX) operates in the SERVICES-TESTING LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $0.28, with a market capitalization of $3.38M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.26 to $50.00. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$3.38M
Open	$0.27
Day's High	$50.00
Day's Low	$0.26
Previous Close	$0.27
Volume	18.34K
Average Volume	98.35K
P/E Ratio	--
52-Week High	$50.00
52-Week Low	$0.26
Dividend Yield	--
Earnings Date	--

20/20 Biolabs, Inc. (AIDX) Latest Closing Stock Price

20/20 Biolabs, Inc. (AIDX) last closed at $0.27 as of 2026-10-21 23:57:00, unchanged from the previous close of $0.27.

During the latest regular trading session, AIDX traded between $0.26 and $50.00, with a volume of 18.34K shares. The closing price was near the lower end and near the lower end of its 52-week range.

20/20 Biolabs, Inc. (AIDX) 7-Day Stock Price Change

Over the past seven days, 20/20 Biolabs, Inc. (AIDX) moved from $0.35 to $0.28, representing a decline of 19.73% ($0.07).

The stock traded between $0.26 and $0.37 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 198.23 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

AIDX 52-Week Price Position

Position in Range: 0.0%

52W Low$0.26

52W High$50.00

AIDX is currently trading at $0.28, placing it 0.0% of the way from its 52-week low of $0.26 to its 52-week high of $50.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is 20/20 Biolabs, Inc. (AIDX)?

20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.

20/20 Biolabs, Inc. Information

Industry	SERVICES-TESTING LABORATORIES
Employees	14
Exchange	NASDAQ
Company Website	https://www.2020biolabs.com

How to Buy 20/20 Biolabs, Inc. (AIDX) Stock on MEXC

Eligible investors can buy real shares of 20/20 Biolabs, Inc. (AIDX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for AIDX and Place Your Order

Open the RealStocks trading page and search for AIDX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is 20/20 Biolabs, Inc. (AIDX) stock price today?

20/20 Biolabs, Inc. (AIDX) is currently trading at $ 0.28, up 6.42% ($0.02) from the previous close of $ 0.27. Intraday prices update in real time during regular trading hours.

2.Is AIDX stock going up or down today?

As of 2026-10-21 23:57:00, AIDX is trading at $ 0.28, up 6.42% ($0.02) from its previous close of $ 0.27. The stock has traded between $ 0.26 and $ 50.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is AIDX pre-market price?

As of 2026-10-21 23:57:00, AIDX is trading at $ 0.27 in pre-market trading, up 1.89% ($0.01) from the previous close of $ 0.27. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is AIDX after-hours price?

As of 2026-10-21 23:57:00, AIDX is trading at $ 0.27 in after-hours trading, up 1.51% ($0.00) from the regular-session close of $ 0.27. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is AIDX stock trading now?

AIDX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does AIDX sit relative to its 52-week high and low?

Over the past 52 weeks, AIDX has traded between a low of $ 0.26 and a high of $ 50.00. At $ 0.28, the stock is positioned 0.0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is 20/20 Biolabs, Inc. in?

20/20 Biolabs, Inc. (AIDX) operates in the SERVICES-TESTING LABORATORIES sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is 20/20 Biolabs, Inc.'s market capitalization and where is it listed?

20/20 Biolabs, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 3.38M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is AIDX valued in terms of P/E ratio and EPS?

AIDX trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does 20/20 Biolabs, Inc. pay a dividend?

20/20 Biolabs, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.